Last year, the APhA–ASP House of Delegates passed Resolution 2021.2, titled “Medication-Assisted Treatment in Vulnerable Patient Populations.” The resolution highlighted the academy’s desire to encourage an increase in access to—and funding for—widespread implementation and utilization of medication-assisted treatment programs for patients suffering from opioid use disorder, specifically in vulnerable patient populations. This was a timely decision given that the most recent data from 2019 estimates that more than 1.4 million people in the United States struggle with a substance use disorder.

As we prepare for APhA2022 in San Antonio this weekend, it’s time to take a look back at the highlights from our last gathering: the APhA–ASP Midyear Regional Meeting (MRM).